title: Internal cue exposure and the treatment of substance use disorders: lessons from the treatment of panic disorder.
abstract: Despite early recognition of the importance of internal cues (craving sensations and emotional states) for relapse in substance use disorders, relatively little attention has been devoted to exposure-based treatments targeting these cues. Drawing upon research on the conceptualization and treatment of panic disorder, we discuss the application of internal (largely emotional) cue exposure for substance use disorders. Our model for this discussion was based on the role of exposure to feared sensations of anxiety in the treatment of panic disorder and benzodiazepine (BZ) discontinuation. Shared research strategies between panic disorder and substance use--studies of biological provocation and anxiety sensitivity--were discussed, as were gender differences in drug-use motives. In accordance with research on anxiety sensitivity, provocation effects, and the treatment of benzodiazepine withdrawal, we discussed the potential value of internal cue-exposure strategies for individuals who use substances as a way to cope with negative affect.
authors.affiliation: Massachusetts General Hospital and Harvard Medical School, WACC-812, 15 Parkman St, Boston, MA 02114, USA. motto@partners.org
authors.forename: Michael W
authors.initials: MW
authors.lastname: Otto
authors.forename: Steven A
authors.initials: SA
authors.lastname: Safren
authors.forename: Mark H
authors.initials: MH
authors.lastname: Pollack
mesh_terms: D014151:Anti-Anxiety Agents / Q000009:adverse effects*; D001007:Anxiety / Q000139:chemically induced*; D001569:Benzodiazepines / Q000009:adverse effects*; D015928:Cognitive Behavioral Therapy / Q000592:standards; D003463:Cues; D006801:Humans; D008960:Models, Psychological; D016584:Panic Disorder / Q000188:drug therapy*; D010554:Personality Disorders / Q000139:chemically induced; D012054:Reinforcement, Psychology; D013375:Substance Withdrawal Syndrome / Q000209:etiology / Q000517:prevention & control
chemical_list: D014151:Anti-Anxiety Agents; D001569:Benzodiazepines